BiocurePharm Corporation announced a non-brokered private placement of 7,692 shares at an issue price of CAD 13.897 per share for gross proceeds of CAD 106,896 on December 2, 2021. The transaction involved participation from returning investor Biocure Technology Inc. and will now hold 94.13% stake in the company.